Mã | Lợi suất đáo hạn % | Khối lượng | Giá % | Phiếu giảm giá % | Ngày đáo hạn | Giá trị dư nợ | Giá trị khuôn mặt | Giá trị mệnh giá tối thiểu | Bên phát hành |
---|---|---|---|---|---|---|---|---|---|
UUS66989HAH1NOVARTIS CAPITAL 14/44 | 5.17% | 0 | 90.00% | 4.40% | 2044-05-06 | 1.85 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
NNVS5894401Novartis Capital Corp. 4.7% 18-SEP-2054 | 5.15% | 90 K | 92.37% | 4.70% | 2054-09-18 | 750 M USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
XXPNDNOVARTIS CAPITAL 15/45 | 5.11% | 0 | 84.77% | 4.00% | 2045-11-20 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
NNVS3904288Novartis Capital Corp. 3.7% 21-SEP-2042 | 5.05% | 2.542 M | 83.33% | 3.70% | 2042-09-21 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
UUS66989HAS7NOVARTIS CAP 20/50 | 4.97% | 0 | 65.10% | 2.75% | 2050-08-14 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
NNVS5894400Novartis Capital Corp. 4.2% 18-SEP-2034 | 4.85% | 5.712 M | 94.85% | 4.20% | 2034-09-18 | 1.1 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
NNVS5894399Novartis Capital Corp. 4.0% 18-SEP-2031 | 4.63% | 108 K | 96.24% | 4.00% | 2031-09-18 | 850 M USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
UUS66989HAR9NOVARTIS CAP 20/30 | 4.56% | 0 | 87.98% | 2.20% | 2030-08-14 | 1.5 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
XXPNCNOVARTIS CAPITAL 15/25 | 4.47% | 0 | 98.50% | 3.00% | 2025-11-20 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
NNVS5894398Novartis Capital Corp. 3.8% 18-SEP-2029 | 4.47% | 3.22 M | 97.08% | 3.80% | 2029-09-18 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
UUS66989HAN8NOVARTIS CAPITAL 17/27 | 4.35% | 0 | 97.01% | 3.10% | 2027-05-17 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
NNVS4950565Novartis Capital Corp. 2.0% 14-FEB-2027 | 4.27% | 340 K | 95.07% | 2.00% | 2027-02-14 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
XXS176904160NOVARTIS FIN. 18/38 | 3.16% | 0 | 83.44% | 1.70% | 2038-08-14 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | Novartis Finance SA |
XXS176904119NOVARTIS FIN. 18/30 | 2.83% | 0 | 92.21% | 1.38% | 2030-08-14 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | Novartis Finance SA |
XXS223599621NOVARTIS FI. 20/28 | 2.73% | 0 | 89.94% | 0.00% | 2028-09-23 | 1.85 B EUR | 1,000.00 EUR | 100,000.00 EUR | Novartis Finance SA |
UUS66989HAP3NOVARTIS CAP 20/25 | 2.59% | 0 | 99.17% | 1.75% | 2025-02-14 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
NNOJANOVARTIS FIN. 17/27 | 2.51% | 0 | 96.11% | 1.13% | 2027-09-30 | 600 M EUR | 1,000.00 EUR | 100,000.00 EUR | Novartis Finance SA |
XXS149282548NOVARTIS FIN. 16/28 | 2.49% | 0 | 93.09% | 0.63% | 2028-09-20 | 500 M EUR | 1,000.00 EUR | 100,000.00 EUR | Novartis Finance SA |
XXS113472979NOVARTIS FIN. 14/26 | 2.49% | 0 | 98.31% | 1.63% | 2026-11-09 | 600 M EUR | 1,000.00 EUR | 100,000.00 EUR | Novartis Finance SA |
CH135325783NOVARTIS 24/40 | 1.08% | 0 | 111.17% | 1.85% | 2040-06-18 | 280 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG |
CH135325784NOVARTIS 24/49 | 1.07% | 0 | 117.04% | 1.85% | 2049-06-18 | 190 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG |
CH27019100NOVARTIS AG 15-35 | 0.99% | 0 | 100.56% | 1.05% | 2035-05-11 | 325 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG |
CH135325782NOVARTIS 24/34 | 0.95% | 0 | 107.40% | 1.75% | 2034-06-16 | 645 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG |
A3LZ2RNOVARTIS INC 2024-18.06.31 REG S | 0.87% | 0 | 105.04% | 1.65% | 2031-06-18 | 435 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG |
NOTCNOVARTIS AG 15-29 | 0.84% | 0 | 98.94% | 0.63% | 2029-11-13 | 550 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG |
CH135325780NOVARTIS 24/27 | 0.74% | 0 | 102.22% | 1.60% | 2027-06-18 | 650 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG |
NOTBNOVARTIS AG 15-25 | 0.48% | 0 | 99.77% | 0.25% | 2025-05-13 | 500 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG |